A Look at Repligen Corp (RGEN) After 4.9% Gain -- GF Value $175.89 vs Price $145.23
Repligen Corp (RGEN) Shares Fall 4.1% -- What GF Score of 83 Tells Investors
Repligen Corp (RGEN) Shares Surge 3.8% -- What GF Score of 83 Tells Investors
Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?
Alger SICAV - Alger Small Cap Focus Fund Q1 2026 Portfolio Update
Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Repligen Has A Cleaner Recovery Angle, But With High Valuation
Repligen Corp (RGEN) Stock Up 8.4% and Still Undervalued -- GF Score: 79/100
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises
Repligen Corporation (RGEN) Q1 2026 Earnings Call Transcript
Repligen (RGEN) Q1 Earnings and Revenues Beat Estimates
Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
Guardant Health (GH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Alger Mid Cap Growth Fund Q1 2026 Portfolio Review
Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for
Conestoga Capital SMid Cap Composite Q1 2026 Portfolio Holdings
Repligen to Report First Quarter 2026 Financial Results
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network
Massachusetts Financial Services Co. MA Makes New $199.18 Million Investment in Repligen Corporation $RGEN
Azzad Asset Management Inc. ADV Has $543,000 Position in Repligen Corporation $RGEN
Repligen (RGEN) Down 13.5% Since Last Earnings Report: Can It Rebound?
Repligen Corporation $RGEN Stock Position Raised by Congress Asset Management Co.
Repligen Conference: CEO touts differentiated bioprocessing portfolio; CFO targets 30% EBITDA margin
Repligen Corporation (RGEN) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
Cinctive Capital Management LP Takes Position in Repligen Corporation $RGEN
Repligen Corporation (NASDAQ:RGEN) Receives Consensus Rating of “Moderate Buy” from Brokerages
Repligen Corporation (RGEN) Presents at Leerink Global Healthcare Conference 2026 Transcript
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y
Repligen Corporation (RGEN) Q4 2025 Earnings Call Transcript
Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates
Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells
Repligen (RGEN) to Release Quarterly Earnings on Thursday
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results
Bessemer Group Inc. Sells 238,450 Shares of Repligen Corporation $RGEN
Conestoga Mid Cap Composite Q4 2025 Leaders And Laggards
Repligen Corporation (RGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair
Delta Investment Management LLC Buys Shares of 50,717 Repligen Corporation $RGEN
Assenagon Asset Management S.A. Takes Position in Repligen Corporation $RGEN
Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows
AWM Investment Company Inc. Sells 12,000 Shares of Repligen Corporation $RGEN
Edgestream Partners L.P. Makes New $3.48 Million Investment in Repligen Corporation $RGEN
Repligen Corporation (RGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript
Advisors Asset Management Inc. Cuts Holdings in Repligen Corporation $RGEN